10/20/2020
RICHLAND, Wash., October 20, 2020 - Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator ...
10/19/2020
RICHLAND, Wash., October 19, 2020 -- Isoray, Inc. (NYSE AMERICAN: ISR) (“Isoray” or the “Company”), a medical ...
09/17/2020
Record Full Year Revenue and Gross Profit
Full Year Revenue Increased 32% Year-Over-Year
RICHLAND, WASHINGTON – ...
09/16/2020
RICHLAND, WASHINGTON – September 16, 2020 – Isoray, Inc. (NYSE American: ISR), a medical technology company and ...
09/10/2020
Conference Call is Thursday, September 17, 2020, at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – September ...
06/17/2020
Trial Will Evaluate Use of Pembrolizumab, Known as Keytruda®*, With Cesium-131 and Surgical Resection RICHLAND, ...
06/02/2020
RICHLAND, WASHINGTON – June 2, 2020 – Isoray, Inc. (NYSE American: ISR) today announced that the results of a new ...
05/12/2020
RICHLAND, WASHINGTON – May 12, 2020 – Isoray, Inc. (NYSE American: ISR) today announced that the Centers for ...
05/12/2020
Record Revenue and Gross Profit
Revenue Increased 50% Year-Over-Year
RICHLAND, WASHINGTON – May 12, 2020 – ...
05/04/2020
Conference Call is May 12 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – May 4, 2020 – Isoray, Inc. (NYSE ...
02/11/2020
Revenue Increased 16% Year-Over-Year
Gross Profit Increased 45% Year-Over-Year
RICHLAND, WASHINGTON – February ...
02/05/2020
Bundled Treatment Program Provides New Opportunities For
Treating Physicians and Patients Facing Limited ...
Media & Public Relations Contact
If you have questions or need help, please contact Sharon Schultz:
Sharon Schultz
Public and Media Relations